FairScope Lab
EN 繁中 简中

ZTS

Valuation Healthcare · Drug Manufacturers - Specialty & Generic Data as of 2026-06-30

P/E Ratio · Metrics

P/E Ratio

10.86

PEG Ratio

0.16

Dividend Yield

-

Gross Margin

72.73%

Net Margin

28.00%

Revenue CAGR 3Y

4.22%

ROE

87.80%

ROA

18.33%

Buyback Yield

1.11%

Current Ratio

3.08

Magic Earn Yield

-

Altman Z-Score

-

Fair Value River

Score

Valuation 86
Profitability 76
Growth 14
Health 100
Yield 19
← Back to Dashboard